Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 864 results for "for merck"

Merck merges pharma, consumer health units; aims to ramp up bu...

MUMBAI: German drug maker Merck has merged its pharmaceuticals and consumer healthcare businesses as part of a major makeover unique to India aimed at building scale and ramping up local business with a hybrid model. Merck's ambition is to push ... Economic Times, 39 minutes ago

807 images for for merck

Mideast Time, 14 hours ago
American Banking News, 1 day ago
Ticker Report, 1 day ago
WKRB News, 3 hours ago
PharmaVOICE, 1 day ago
Ticker Report, 1 day ago
WKRB News, 1 day ago
European Coatings, 1 day ago
World Pharma News, 3 days ago
Pharma Letter, 5 hours ago

Merck's Antiviral Medicine Meets Endpoint in Phase III

Merck & Co., Inc. MRK announced that a phase III study on its antiviral pipeline candidate, letermovir met the primary endpoint. Letermovir is being developed for the treatment of cytomegalovirus (CVM) infections.The study assessed the safety and ...
 Zacks.com5 hours ago Merck's letermovir successful in preventing CMV infection in late-stage study  Seeking Alpha1 day ago BRIEF-Merck says phase 3 study with Letermovir meets its primary endpoint  Reuters UK1 day ago MSD's antiviral drug hits endpoint targets in Phase III trials  Pharmafile10 hours ago
Contract Pharma

BRIEF-Debiopharm reports clinical collaboration with Merck KGaA and Pfizer

n"Oct 20 Pfizer Inc : * Debiopharm International SA announces clinical collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer in cancer immunotherapy * Debiopharm International - under terms of agreement, Debiopharm will be responsible for ...
 Reuters UK7 hours ago Debiopharm International SA Announces Clinical Collaboration with the Merck-Pfizer Alliance in Cancer..  ADVFN India8 hours ago Debiopharm, Merck KGaA, Pfizer in Clinical Collaboration  Contract Pharma1 hour ago ArticleDebiopharm collaborates with Merck and Pfizer on cancer immunotherapy20-10-2016  Pharma Letter4 hours ago

Debiopharm International SA annonce sa collaboration clinique avec Merck KGaA, Darmstadt, Allemagne, et Pfizer dans l'immunothérapie du cancer

Cet effort commun se concentrera initialement sur un essai de phase I/Ib portant sur des patients atteints d'un cancer du poumon afin d'évaluer la sécurité et l'efficacité préliminaire du Debio 1143 en combiné à l'avelumab. LAUSANNE, ...
 Canada NewsWire8 hours ago
Biz Community

Ivory Coast benefits from schistosomiasis programme

At a school located roughly 25 km north-west of Abidjan, representatives from Merck, the World Health Organisation (WHO) and Ivory Coast's ministry of health announced the launch of a praziquantel tablet distribution programme to fight ...
 Biz Community11 hours ago

Merck at K 2016: Showcases Effect Pigments for Polymer Stability

DARMSTADT, Germany -- Merck presents innovative effect pigments and processes at K 2016, the top trade fair for plastics and rubber, from October 19to 26 in Düsseldorf, Germany. In Hall 8a at Stand E40, visitors can see the fascinating effects of ...
 SpecialChem Polymer Additives23 hours ago MERCK : Showcases Innovative Effect Pigments and Processes at K2016  4 Traders2 days ago

Advaxis Initiates Combination Portion of Phase 1/2 Study with Merck

Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced the commencement of Part B of the KEYNOTE-046 clinical trial evaluating Advaxis Lm immunotherapy candidate, ADXS-PSA, in ...
 Minyanville9 hours ago BRIEF-Advaxis initiates combination portion of phase 1/2 study with Merck  Reuters UK8 hours ago

Blog Coverage Merck FDA Fast Tracked Antiviral Medicine Hits Phase III Target

/ Active Wall St. blog coverage looks at the headline from Merck & Co. Inc. (NYSE: MRK ) as the company announced announced on October 19th, 2016, that the pivotal Phase 3 clinical study of its FDA fast tracked investigational antiviral medicine ...
 Nation's Restaurant News8 hours ago

Merck to hold board meeting

On 11 November 2016
 Business Standard1 day ago Merck's board meeting on November 11, 2016  Money Control1 day ago Merck Ltd calls for Board Meeting on Nov 11, 2016  Equity Bulls13 hours ago

Merck's antiviral drug meets main goal in late-stage trial

Oct 19 (Reuters) - Merck & Co Inc said its experimental drug to prevent cytomegalovirus infection in high-risk bone marrow transplant patients met its primary goal in a late-stage trial. Cytomegalovirus is a member of the herpes virus family and ...
 Yahoo! Finance1 day ago UPDATE 1-Merck's antiviral drug meets main goal in late-stage trial  Business Insider14 hours ago Merck's antiviral drug meets goal in late-stage trial  Pharma Live1 day ago Merck scraps development of osteoporosis drug due to stroke risk  Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less